|
1.
|
Nguyen DM and El-Serag HB: The
epidemiology of obesity. Gastroenterol Clin North Am. 39:1–7. 2010.
View Article : Google Scholar
|
|
2.
|
Jia WP, Wang C, Jiang S and Pan JM:
Characteristics of obesity and its related disorders in China.
Biomed Environ Sci. 23:4–11. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Schrauwen P and Westerterp KR: The role of
high-fat diets and physical activity in the regulation of body
weight. Br J Nutr. 84:417–427. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Pagliassotti MJ, Gayles EC and Hill JO:
Fat and energy balance. Ann NY Acad Sci. 827:431–448. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Nair RP and Ren J: Pharmacotherapy of
obesity – benefit, bias and hyperbole. Curr Med Chem. 16:1888–1897.
2009.
|
|
6.
|
Jackman MR, MacLean PS and Bessesen DH:
Energy expenditure in obesity-prone and obesity-resistant rats
before and after the introduction of a high-fat diet. Am J Physiol
Regul Integr Comp Physiol. 299:R1097–R1105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Takahashi N, Patel HR, Qi Y, et al:
Divergent effects of leptin in mice susceptible or resistant to
obesity. Horm Metab Res. 34:691–697. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Primeaux SD, Barnes MJ and Bray GA:
Olfactory bulbectomy increases food intake and hypothalamic
neuropeptide Y in obesity-prone but not obesity-resistant rats.
Behav Brain Res. 180:190–196. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Ji H and Friedman MI: Reduced hepatocyte
fatty acid oxidation in outbred rats prescreened for susceptibility
to diet-induced obesity. Int J Obesity. 32:1331–1334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Trinder P: Determination of glucose in
blood using glucose oxidase with an alternative oxygen acceptor.
Ann Clin Biochem. 6:24–27. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Allain CC, Poon LC, Chan CS, et al:
Enzymatic determination of total cholesterol. Clin Chem.
20:470–475. 1974.PubMed/NCBI
|
|
12.
|
Fossati P and Prencipe L: Serum
triglycerides determined colorimetrically with an enzyme that
produce hydrogen peroxide. Clin Chem. 28:2077–2080. 1982.PubMed/NCBI
|
|
13.
|
Izzo C, Grillo F and Murador E: Improved
method for determination of high-density-lipoprotein cholesterol I.
Isolation of high-density lipoproteins by use of polyethylene
glycol 6000. Clin Chem. 27:371–374. 1981.PubMed/NCBI
|
|
14.
|
Kerscher L, Schiefer S, Draeger B, et al:
Precipitation methods for the determination of LDL-cholesterol.
Clin Biochem. 18:118–125. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Xie WD, Wang H, Zhang JF, et al: Proteomic
profile of visceral adipose tissues between low-fat diet-fed
obesity-resistant and obesity-prone C57BL/6 mice. Mol Med Rep.
3:1047–1052. 2010.PubMed/NCBI
|
|
16.
|
Guo Y, Jolly RA, Halstead BW, et al:
Underlying mechanisms of pharmacology and toxicity of a novel PPAR
agonist revealed using rodent and canine hepatocytes. Toxicol Sci.
96:294–309. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Pagliassotti MJ, Knobel SM, Shahrokhi KA,
et al: Time course of adaptation to a high-fat diet in
obesity-resistant and obesity-prone rats. Am J Physiol.
267:R659–R664. 1994.PubMed/NCBI
|
|
18.
|
Xie WD, Zhang YO, Wang NL, et al: Novel
effects of macrostemonoside A, a compound from Allium
macrostemon Bung, on hyperglycemia, hyperlipidemia, and
visceral obesity in high-fat diet-fed C57BL/6 mice. Eur J
Pharmacol. 599:159–165. 2008.PubMed/NCBI
|
|
19.
|
Trayhurn P and Beattie JH: Physiological
role of adipose tissue: white adipose tissue as an endocrine and
secretory organ. Proc Nutr Soc. 60:329–339. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Rosicka M, Krsek M, Matoulek M, et al:
Serum ghrelin levels in obese patients: the relationship to serum
leptin levels and soluble leptin receptor levels. Physiol Res.
52:61–66. 2003.PubMed/NCBI
|
|
21.
|
Luo JD, Zhang GS and Chen MS: Leptin and
cardiovascular diseases. Timely Top Med Cardiovasc Dis.
9:E342005.PubMed/NCBI
|
|
22.
|
Kannel WB and Vasan RS: Triglycerides as
vascular risk factors: new epidemiologic insights. Curr Opin
Cardiol. 24:345–350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Swinburn B, Sacks G and Ravussin E:
Increased food energy supply is more than sufficient to explain the
US epidemic of obesity. Am J Clin Nutr. 90:1453–1456. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Kaplan LM: Pharmacologic therapies for
obesity. Gastroenterol Clin North Am. 39:69–79. 2010. View Article : Google Scholar
|
|
25.
|
Huzarewich RL, Siemens CG and Booth SA:
Application of “omics” to prion biomarker discovery. J Biomed
Biotechnol. 2010:6135042010.
|
|
26.
|
Halvorsen YD, Wilkison WO and Briggs MR:
Human adipocyte proteomics – a complementary way of looking at fat.
Pharmacogenomics. 1:179–185. 2000.
|
|
27.
|
FitzPatrick DR, Germain-Lee E and Valle D:
Isolation and characterization of rat and human cDNAs encoding a
novel putative peroxisomal enoyl-CoA hydratase. Genomics.
27:457–466. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Aoyama T, Peters JM, Iritani N, et al:
Altered constitutive expression of fatty acid-metabolizing enzymes
in mice lacking the peroxisome proliferator-activated receptor
alpha (PPARalpha). J Biol Chem. 273:5678–5684. 1998. View Article : Google Scholar
|
|
29.
|
Xie WD, Nie Y, Du LJ, et al: Preventive
effects of fenofibrate on insulin resistance, hyperglycaemia,
visceral fat accumulation in NIH mice induced by small-dose
streptozotocin and lard. Pharmacol Res. 55:392–399. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Abbott BD: Review of the expression of
peroxisome proliferator-activated receptors alpha (PPAR alpha),
beta (PPAR beta), and gamma (PPAR gamma) in rodent and human
development. Reprod Toxicol. 27:246–257. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Miyazaki M, Nakagawa I, Koga S, et al:
Proteomics analysis of cardiac muscle from rats with peroxisomal
proliferator-activated receptor alpha (PPARalpha) stimulation. J
Toxicol Sci. 35:131–135. 2010. View Article : Google Scholar
|
|
32.
|
Tsai YS and Maeda N: PPARgamma: a critical
determinant of body fat distribution in humans and mice. Trends
Cardiovasc Med. 15:81–85. 2005. View Article : Google Scholar : PubMed/NCBI
|
